Spotlight Asset Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $60K | Hold |
20,000
| – | – | 0.04% | 129 |
|
|
2024
Q1 | $93K | Hold |
20,000
| – | – | 0.07% | 113 |
|
|
2023
Q4 | $60K | Hold |
20,000
| – | – | 0.05% | 126 |
|
|
2023
Q3 | $60K | Hold |
20,000
| – | – | 0.05% | 126 |
|
|
2023
Q2 | $49.2K | Hold |
20,000
| – | – | 0.04% | 138 |
|
|
2023
Q1 | $140K | Buy |
+20,000
| New | +$140K | 0.14% | 72 |
|
|
2022
Q3 | $140K | Buy |
+20,000
| New | +$140K | 0.14% | 72 |
|
|
2021
Q3 | $793K | Hold |
30,265
| – | – | 0.4% | 51 |
|
|
2021
Q2 | $969K | Buy |
30,265
+5,700
| +23% | +$182K | 0.37% | 53 |
|
|
2021
Q1 | $865K | Buy |
24,565
+1,856
| +8% | +$65.4K | 0.33% | 60 |
|
|
2020
Q4 | $728K | Buy |
+22,709
| New | +$728K | 0.27% | 58 |
|